At this time, I would like to welcome everyone to the 10x Genomics, Inc. Fourth Quarter and Full Year 2025 Earnings Call.
CVRx (NASDAQ:CVRX) reported fourth-quarter revenue of $16.0 million and full-year revenue of $56.7 million, representing growth of 4% and 10%, respectively, as the company continued investing in its c ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results